Your friend Boris makes the following statement: ‘I’m buying shares in a biotech company. They recently...

Your friend Boris makes the following statement:
‘I’m buying shares in a biotech company. They recently announced third stage FDA trials on a new Alzheimer drug, and it’s got the potential to turn into a huge market.’
What facts need to be true for your friend’s rationale to be correct?

Solutions

Expert Solution

The information is given about the start of the third phase trial for the Alzheimer drug, which is one of the most crucial stage in the drug approval route as it involves testing the drug in a large population, which could involve many years (7-15 years) for the result to show. Moving to 3rd stage is definitely a positive sign, however, there are other parameters both qualitative and quantitative measures that could be looked at. The past patents and Ip's already existing for the company. The rate of success in past applications and the process of the approval routes. Evaluating the quality of management of the company.

Coming on the financial numbers, parameters such as cash & equivalent for short and long term obligations, the capital structure especially the debt component, P/E, PEG etc are few things which would be definitely checked first hand to check the potential for huge markets.

Kindly check the reference which will give good knowledge about pharma stocks in general:-

https://www.fool.com/investing/how-to-invest-in-pharmaceutical-stocks.aspx

jeff jeffy answered 1 year ago

Next > < Previous

Related Solutions

Biotech company is considering buying a machine. The cashflows at the beginning of the year for...

Biotech company is considering buying a machine. The cashflows at the beginning of the year for each machine are shown in the following table. Assume a rate of return of 12%. Find the IRR and NPV of each machine. Which machine should Biotech buy? Do the machines have a unique IRR? Justify your answers. Time Year 0 Year 1 Year 2 Year 3 Year 4 Machine 1 -150 20 130 50 26 Machine 2 -90 -90 200 36 36

A manager of a medium-sized private company recently asked for your advice on the following: I’m very confused about whether I should continue to ...

A manager of a medium-sized private company recently asked for your advice on the following:I’m very confused about whether I should continue to use ASPE or change to IFRS. I need to make a recommendation to the Board next week on what we should do. Our bank is a Canadian one and we have a debt-to-equity ratio. Our two major competitors in the market place are public companies. We have no desire to go public in the near future, but...

Your friend Mr. Fawad has recently joined a multinational company as an Asst. Manager. He has...

Your friend Mr. Fawad has recently joined a multinational company as an Asst. Manager. He has observed his Manager indulging into taking bribe at times. Mr. Fawad overheard on the phone his manager leaking company’s private information with the competitors. Fawad’s promotion can be decided only by this Manager. If Mr. Fawad doesn’t keep him happy, he will have to forget his promotion. If new Manager comes, Fawad’s promotion will be postponed for a very long time till he satisfies...

Suppose your friend Shamiul works in a textile company and recently they are going to buy a new machine for the plant.

Suppose your friend Shamiul works in a textile company and recently they are going to buy a new machine for the plant. He is calculating the acceptability of the project. The targeted payback period for the project is 2.5 years. Expected net costs are listed in the following table: Calculate the payback period (with timeline) of the project and decide whether he should invest in this project or not.

You are a researcher at a small biotech company and your company has just obtained the...

You are a researcher at a small biotech company and your company has just obtained the license for use of a human GENOMIC DNA fragment putatively encoding a potentially novel protein, which is thought to regulate p53, the known tumor supressor protein. The scientists who originally cloned this GENE fragment HDM5 "claim" that HDM5 shares 90% DNA sequence homology with one of the HDM2 genes (refer to the review Levine & Oren, 2009). They propose that HDM5 may have HDM2-like...

You are a researcher at a small biotech company and your company has just obtained the...

You are a researcher at a small biotech company and your company has just obtained the license for use of a human GENOMIC DNA fragment putatively encoding a potentially novel protein, which is thought to regulate p53, the known tumor supressor protein. The scientists who originally cloned this GENE fragment HDM5 "claim" that HDM5 shares 93% DNA sequence homology with one of the HDM2 genes (refer to the review Levine & Oren, 2009). They propose that HDM5 may have HDM2-like...

X Company currently makes a part and is considering buying it from a company that has...

X Company currently makes a part and is considering buying it from a company that has offered to supply it for $19.69 per unit. This year, per-unit production costs to produce 17,000 units were: Direct materials $8.40 Direct labor 5.80 Overhead 6.90 Total $21.10 $51,000 of the total overhead costs were fixed. $29,580 of the fixed overhead costs are avoidable if X Company buys the part. If the company buys the part, the resources that are used to make it...

X Company currently makes a part and is considering buying it from a company that has...

X Company currently makes a part and is considering buying it from a company that has offered to supply it for $18.54 per unit. This year, per-unit production costs to produce 15,000 units were: Direct materials $8.30 Direct labor 5.20 Overhead 6.40 Total $19.90 $52,500 of the total overhead costs were variable. $17,400 of the fixed overhead costs are unavoidable if X Company buys the part. If the company buys the part, the resources that are used to make it...

X Company currently makes a part and is considering buying it from a company that has...

X Company currently makes a part and is considering buying it from a company that has offered to supply it for $18.93 per unit. This year, per-unit production costs to produce 20,000 units were: Direct materials $8.30 Direct labor 5.80 Overhead 5.50 Total $19.60 $44,000 of the total overhead costs were fixed. $25,520 of the fixed overhead costs are avoidable if X Company buys the part. If the company buys the part, the resources that are used to make it...

Subjects